Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong

INTRODUCTION: The risk of new onset depression associated with sodium-glucose co-transporter 2 inhibitor (SGLT2I) use in patients with type 2 diabetes mellitus (T2DM) remains unclear. This study investigated the risk of new onset depression between SGLT2I and dipeptidyl peptidase 4 inhibitor (DPP4I)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mui, Jonathan V., Li, Lifang, Chou, Oscar Hou In, Azfar, Nida, Lee, Athena, Hui, Jeremy, Lee, Sharen, Tse, Gary, Zhou, Jiandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198893/
https://www.ncbi.nlm.nih.gov/pubmed/37000300
http://dx.doi.org/10.1007/s00592-023-02063-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198893/
https://www.ncbi.nlm.nih.gov/pubmed/37000300
http://dx.doi.org/10.1007/s00592-023-02063-6

Ejemplares similares